glicentin has been researched along with exenatide in 1 studies
| Studies (glicentin) | Trials (glicentin) | Recent Studies (post-2010) (glicentin) | Studies (exenatide) | Trials (exenatide) | Recent Studies (post-2010) (exenatide) |
|---|---|---|---|---|---|
| 86 | 8 | 22 | 2,806 | 383 | 2,016 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Aydin, BK; Bergsten, P; Cerenius, SY; Chowdhury, A; Ciba, I; Forslund, A; Gjessing, ES; Gomahr, J; Heu, V; Kristinsson, H; Manell, H; Mörwald, K; Stenlid, R; Weghuber, D; Wen, Q | 1 |
1 other study(ies) available for glicentin and exenatide
| Article | Year |
|---|---|
Adolescents with obesity treated with exenatide maintain endogenous GLP-1, reduce DPP-4, and improve glycemic control.
Topics: Adolescent; Child; Exenatide; Glicentin; Glucagon; Glucagon-Like Peptide 1; Glucose; Glycemic Control; Humans; Insulin; Pediatric Obesity; Proinsulin | 2023 |